The case presented of a CD30+ CTCL in a 3-year-old male is a rare event where treatment was altered by a diagnostic procedure well established for other cutaneous malignancies, but not frequently used for CTCL. This evidence concerns the gene TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma.